Clinical Trial

Dropless Pars Plana Vitrectomy Study

Study acronym: DVS
Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated June 26, 2026 (before its estimated July 25, 2026 completion). Its status may not reflect the trial's current state.
Summary
To demonstrate that intraoperative use of subtenon triamcinolone acetonide at the time of surgery without postoperative eye drops is non-inferior to the regimen of postoperative eye drops following primary pars plana vitrectomy for retinal detachment.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2022-04-09; most recent amendment 2026-06-23.
Status change: Not Yet Recruiting → Recruiting 2022-07-26
Trial Details
NCT Number NCT05331664
Lead Sponsor Massachusetts Eye and Ear Infirmary
Conditions Rhegmatogenous Retinal Detachment
Enrollment 168 participants
Start Date 2022-07-25
Primary Completion 2026-07-25 (estimated)
Study Completion 2027-01-30 (estimated)
Updated on ClinicalTrials.gov 2026-06-26